Neutral Notes & Education Series

Educational Articles by:

Denise Macklin, BSN, RNC
Fran Powers, RN, MA, MEd., CRNI

  1. 06.22.09PDF DocumentReimbursement in the Alternate Care Setting
  2. 06.15.09PDF DocumentSpecial Considerations in Preventing Thrombotic Catheter Occlusions And CR-BSI in the Alternate Care Setting
  3. 03.28.08PDF DocumentCR-BSI Prevention With A Care & Maintenance BundleRyMed Technologies, Inc. is pleased to offer this first edition of our 2008 newsletter, Neutral Notes™. The focus of this edition is RyMed’s Net Zero™ Catheter Management Program. This program is designed to provide a roadmap to dramatic reductions in your catheter-related bloodstream infection (CRBSI) and intraluminal thrombotic catheter occlusion rates.
  4. 09.01.06PDF DocumentI.V. Connector Design - Impact on Biofilm & CR-BSIthis newsletter is to provide important information related to infusion therapy and needle-free I.V. connectors. This edition’s focus will be on the topic of catheter related bloodstream infections (CRBSI). Ninety-six percent of bloodstream infections are primary bacteremias. Eighty-five percent of these are catheter related and results in increased hospitalization by 5 – 20 days. The attributable mortality is 2% – 15%. The attributable cost is $34,000 to $56,000 per episode. Annually the cost to healthcare is over 11 billion dollars.
  5. 07.28.06PDF DocumentThe Origin of Thrombotic Occlusion - Diagnosis & ManagementRyMed Technologies, Inc. is pleased to offer this first edition of our quarterly newsletter, Neutral Notes. The purpose of this newsletter is to provide important information related to infusion therapy and needle-free I.V. connectors. This edition's focus will be on the topic of occlusion.
Showing 1 - 5 of 5 Articles | Page 1 of 1
< Previous 1 Next >
Client Log-in
Submit
Staff Log-in
Submit
Corporate Headquarters
RyMed Technologies, Inc.
137 Third Avenue North
Franklin, TN 37064
Phone: 615-790-8093
FAX: 615-790-8984
E-Mail: info@rymedtech.com